{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:02:14Z","timestamp":1791230534412,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/mph.0000000000000440","type":"journal-article","created":{"date-parts":[[2015,10,17]],"date-time":"2015-10-17T15:34:06Z","timestamp":1445096046000},"page":"e468-e474","source":"Crossref","is-referenced-by-count":20,"title":["Which Variables Are Useful for Predicting Severe Infection in Children With Febrile Neutropenia?"],"prefix":"10.1097","volume":"37","author":[{"given":"Mathilde","family":"Delebarre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Macher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Thebaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Mazingue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Duhamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Martinot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Dubos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20221016","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijantimicag.2005.08.007","article-title":"Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever","volume":"26","author":"Jun","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"R2-17-20221016","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0021-9681(62)90023-1","article-title":"Use of antibiotics in cancer and leukemia","volume":"15","author":"Curtin","year":"1962","journal-title":"J Chronic Dis"},{"key":"R3-17-20221016","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.emc.2009.04.007","article-title":"Fever and neutropenia in pediatric patients with cancer","volume":"27","author":"Meckler","year":"2009","journal-title":"Emerg Med Clin North Am"},{"key":"R4-17-20221016","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2334-8-80","article-title":"Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study","volume":"8","author":"Irfan","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R5-17-20221016","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1200\/JCO.2004.01.077","article-title":"Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents\u2019 and healthcare professionals\u2019 preferences","volume":"22","author":"Sung","year":"2004","journal-title":"J Clin Oncol"},{"key":"R6-17-20221016","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1200\/JCO.2007.13.8222","article-title":"Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia","volume":"26","author":"Elting","year":"2008","journal-title":"J Clin Oncol"},{"key":"R7-17-20221016","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2141.1997.4453255.x","article-title":"A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"99","author":"Hann","year":"1997","journal-title":"Br J Haematol"},{"key":"R8-17-20221016","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R9-17-20221016","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1200\/JCO.2012.42.7161","article-title":"Guideline for the management of fever and neutropenia in children with cancer and\/or undergoing hematopoietic stem-cell transplantation","volume":"30","author":"Lehrnbecher","year":"2012","journal-title":"J Clin Oncol"},{"key":"R10-17-20221016","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pbc.22586","article-title":"Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia","volume":"55","author":"Macher","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R11-17-20221016","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/pbc.20810","article-title":"Management of febrile neutropenia in pediatric oncology patients: a Canadian survey","volume":"48","author":"Boragina","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R12-17-20221016","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00043426-200201000-00011","article-title":"Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer","volume":"24","author":"Alexander","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"R13-17-20221016","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/1097-0142(20010815)92:4<909::AID-CNCR1400>3.0.CO;2-H","article-title":"Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia","volume":"92","author":"Baorto","year":"2001","journal-title":"Cancer"},{"key":"R14-17-20221016","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.1996.14.3.919","article-title":"Predicting the risk of bacteremia in children with fever and neutropenia","volume":"14","author":"Rackoff","year":"1996","journal-title":"J Clin Oncol"},{"key":"R15-17-20221016","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1200\/JCO.2000.18.5.1012","article-title":"\u201cLow-risk\u201d prediction rule for pediatric oncology patients presenting with fever and neutropenia","volume":"18","author":"Klaassen","year":"2000","journal-title":"J Clin Oncol"},{"key":"R16-17-20221016","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2001.19.14.3415","article-title":"Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever","volume":"19","author":"Santolaya","year":"2001","journal-title":"J Clin Oncol"},{"key":"R17-17-20221016","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mpo.10320","article-title":"Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection","volume":"41","author":"Ammann","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"R18-17-20221016","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.inf.0000106782.30100.4f","article-title":"Predicting bacteremia in children with fever and chemotherapy-induced neutropenia","volume":"23","author":"Ammann","year":"2004","journal-title":"Pediatr Infect Dis"},{"key":"R19-17-20221016","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.mph.0000212996.94929.0b","article-title":"A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia","volume":"28","author":"Rondinelli","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"R20-17-20221016","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1086\/342064","article-title":"Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia","volume":"35","author":"Santolaya","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R21-17-20221016","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/pbc.25106","article-title":"Which decision rules meet methodological standards in children with febrile neutropenia? Results of a systematic review and analysis","volume":"61","author":"Delebarre","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R22-17-20221016","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.ejca.2010.05.024","article-title":"Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people","volume":"46","author":"Phillips","year":"2010","journal-title":"Eur J Cancer"},{"key":"R23-17-20221016","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.284.1.79","article-title":"Users\u2019 guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group","volume":"284","author":"McGinn","year":"2000","journal-title":"JAMA"},{"key":"R24-17-20221016","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1542\/peds.2011-0043","article-title":"Clinical prediction rules for children: a systematic review","volume":"128","author":"Maguire","year":"2011","journal-title":"Pediatrics"},{"key":"R25-17-20221016","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/522533","article-title":"A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation","volume":"45","author":"Castagnola","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R26-17-20221016","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/pbc.21184","article-title":"Classifying the intensity of pediatric cancer treatment protocols: the Intensity of Rating Scale 2.0 (ITR-2)","volume":"48","author":"Werba","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R28-17-20221016","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R29-17-20221016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis conference: definitions for sepsis and organ dysfunction in paediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R31-17-20221016","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MOH.0b013e32834da951","article-title":"Predicting the risk of severe infection in children with chemotherapy-induced febrile neutropenia","volume":"19","author":"Dubos","year":"2012","journal-title":"Curr Opin Hematol"},{"key":"R32-17-20221016","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.1997.03540300056034","article-title":"Clinical prediction rules. A review and suggested modifications of methodological standards","volume":"277","author":"Laupacis","year":"1997","journal-title":"JAMA"},{"key":"R33-17-20221016","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/INF.0b013e3181673c3c","article-title":"Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia, and fever: a prospective, multicenter trial","volume":"27","author":"Santolaya","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R34-17-20221016","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2009.25.8988","article-title":"Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study","volume":"28","author":"Ammann","year":"2010","journal-title":"J Clin Oncol"},{"key":"R35-17-20221016","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00520-010-0987-6","article-title":"The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia","volume":"19","author":"Miedema","year":"2011","journal-title":"Support Care Cancer"},{"key":"R36-17-20221016","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0196-0644(99)70309-4","article-title":"Methodologic standards for the development of clinical decision rules in emergency medicine","volume":"33","author":"Stiell","year":"1999","journal-title":"Ann Emerg Med"},{"key":"R37-17-20221016","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2257.1996.tb01289.x","article-title":"Automated leucocyte differentials in 292 patients with leucopenia: an evaluation of the Abbott CELL-DYN 3500 (CD3500) haematology analyser","volume":"18","author":"Burchert-Graeve","year":"1996","journal-title":"Clin Lab Haematol"},{"key":"R38-17-20221016","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting Posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Shichter","year":"2005","journal-title":"Blood"},{"key":"R39-17-20221016","first-page":"555","article-title":"Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score","volume":"2","author":"Uys","year":"2004","journal-title":"Support Care Cancer"},{"key":"R40-17-20221016","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J Clin Oncol"},{"key":"R41-17-20221016","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1473-3099(04)01146-6","article-title":"Procalcitonin as an early marker of infection in neonates and children","volume":"4","author":"Van Rossum","year":"2004","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201511000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,16]],"date-time":"2022-10-16T23:01:04Z","timestamp":1665961264000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201511000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000440","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}